NU Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -146,594 | -110,489 | -118,791 | -533 | 8,595 |
| Depreciation Amortization | 69,810 | 53,361 | 36,040 | 18,437 | 70,923 |
| Income taxes - deferred | -55,477 | -7,625 | -2,314 | 1,348 | -18,090 |
| Accounts receivable | -7,763 | 5,074 | 1,394 | 7,447 | -22,679 |
| Accounts payable and accrued liabilities | -7,294 | -10,556 | -6,109 | -10,575 | -10,083 |
| Other Working Capital | -28,335 | -38,667 | -36,019 | -32,023 | -81,683 |
| Other Operating Activity | 287,395 | 194,859 | 180,324 | 19,217 | 171,656 |
| Operating Cash Flow | $111,742 | $85,957 | $54,525 | $3,318 | $118,639 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41,583 | -29,000 | -20,404 | -12,281 | -58,490 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -77,275 |
| Purchase Of Investment | -14,757 | -13,718 | -8,567 | N/A | -16,883 |
| Sale Of Investment | 18,378 | 18,378 | 11,178 | 3,019 | 18,147 |
| Investing Cash Flow | $-37,962 | $-24,340 | $-17,793 | $-9,262 | $-134,501 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | 0 | N/A | 110,000 |
| Debt Repayment | -127,886 | -87,302 | -46,560 | -20,785 | -13,198 |
| Common Stock Issued | -2,063 | -2,004 | -1,951 | -1,891 | 4,561 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -13,011 |
| Dividend Paid | -11,927 | -8,944 | -5,961 | -2,979 | -77,622 |
| Other Financing Activity | -6,300 | -6,300 | -6,300 | -6,300 | 0 |
| Financing Cash Flow | $-133,176 | $-89,550 | $-60,772 | $-31,955 | $10,730 |
| Exchange Rate Effect | -9,778 | -373 | -7,767 | -5,626 | -3,536 |
| Beginning Cash Position | 256,057 | 256,057 | 256,057 | 256,057 | 264,725 |
| End Cash Position | 186,883 | 227,751 | 224,250 | 212,532 | 256,057 |
| Net Cash Flow | $-69,174 | $-28,306 | $-31,807 | $-43,525 | $-8,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,742 | 85,957 | 54,525 | 3,318 | 118,639 |
| Capital Expenditure | -41,583 | -29,000 | -20,404 | -12,281 | -58,490 |
| Free Cash Flow | 70,159 | 56,957 | 34,121 | -8,963 | 60,149 |